Literature DB >> 30712794

Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species.

A J Villatoro1, C Alcoholado2, M C Martín-Astorga3, V Fernández1, M Cifuentes3, J Becerra4.   

Abstract

The two main sources of mesenchymal stem cell (MSCs) in the canine species are bone marrow (cBM-MSCs) and adipose tissue (cAd-MSCs). The secretion of multitude bioactive molecules, included under the concept of secretome and found in the cultured medium, play a predominant role in the mechanism of action of these cells on tissue regeneration. Although certain features of its characterization are well documented, their secretory profiles remain unknown. We described and compared, for the first time, the secretory profile and exosomes characterization in standard monolayer culture of MSCs from both sources of the same donor as well as its immunomodulatory potential. We found that despite the similarity in surface immunophenotyping and trilineage differentiation, there are several differences in terms of proliferation rate and secretory profile. cAd-MSCs have advantages in proliferative capacity, whereas cBM-MSCs showed a significantly higher secretory production of some soluble factors (IL-10, IL-2, IL-6, IL-8, IL-12p40, IFN-γ, VEGF-A, NGF-β, TGF-β, NO and PGE2) and exosomes under the same standard culture conditions. Proteomics analysis confirm that cBM-MSCs exosomes have a greater number of characterized proteins involved in metabolic processes and in the regulation of biological processes compared to cAd-MSCs. On the other hand, secretome from both sources demonstrate similar immunomodulatory capacity when tested in mitogen stimulated lymphocyte reaction, but not in their exosomes at the dose used. Considering that the use of secretome open as a new therapeutic strategy for different diseases, without the need to implant cells, those biological differences should be considered, when choosing the MSCs source, for either cellular implantation or direct use of secretome for a specific clinical application.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell therapy; Exosomes; Mesenchymal stem cells; Regenerative medicine; Secretome

Mesh:

Substances:

Year:  2018        PMID: 30712794     DOI: 10.1016/j.vetimm.2018.12.003

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  23 in total

1.  Secretory Profile of Adipose-Tissue-Derived Mesenchymal Stem Cells from Cats with Calicivirus-Positive Severe Chronic Gingivostomatitis.

Authors:  Antonio J Villatoro; María Del Carmen Martín-Astorga; Cristina Alcoholado; Liliya Kazantseva; Casimiro Cárdenas; Fernando Fariñas; José Becerra; Rick Visser
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

2.  Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration.

Authors:  Meadhbh Á Brennan; Pierre Layrolle; David J Mooney
Journal:  Adv Funct Mater       Date:  2020-03-11       Impact factor: 18.808

Review 3.  Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies.

Authors:  Kangkang Zha; Yu Yang; Guangzhao Tian; Zhiqiang Sun; Zhen Yang; Xu Li; Xiang Sui; Shuyun Liu; Jinmin Zhao; Quanyi Guo
Journal:  Stem Cells Transl Med       Date:  2021-02-15       Impact factor: 6.940

Review 4.  Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.

Authors:  Carl Randall Harrell; Crissy Fellabaum; Nemanja Jovicic; Valentin Djonov; Nebojsa Arsenijevic; Vladislav Volarevic
Journal:  Cells       Date:  2019-05-16       Impact factor: 6.600

5.  Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation.

Authors:  Nopmanee Taechangam; Smita S Iyer; Naomi J Walker; Boaz Arzi; Dori L Borjesson
Journal:  Stem Cell Res Ther       Date:  2019-06-25       Impact factor: 6.832

6.  Canine colostrum exosomes: characterization and influence on the canine mesenchymal stem cell secretory profile and fibroblast anti-oxidative capacity.

Authors:  Antonio J Villatoro; María Del Carmen Martín-Astorga; Cristina Alcoholado; José Becerra
Journal:  BMC Vet Res       Date:  2020-11-02       Impact factor: 2.741

Review 7.  Mesenchymal Stem Cell-Mediated Immuno-Modulatory and Anti- Inflammatory Mechanisms in Immune and Allergic Disorders.

Authors:  Mudasir B Gugjoo; Shahid Hussain; Riaz A Shah; Kuldeep Dhama
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2020

Review 8.  Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?

Authors:  Michela Mocchi; Silvia Dotti; Maurizio Del Bue; Riccardo Villa; Elia Bari; Sara Perteghella; Maria Luisa Torre; Stefano Grolli
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

Review 9.  Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration.

Authors:  Dae Hyun Ha; Hyun-Keun Kim; Joon Lee; Hyuck Hoon Kwon; Gyeong-Hun Park; Steve Hoseong Yang; Jae Yoon Jung; Hosung Choi; Jun Ho Lee; Sumi Sung; Yong Weon Yi; Byong Seung Cho
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

10.  A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis.

Authors:  Christopher Centeno; Zachary Fausel; Ian Stemper; Ugochi Azuike; Ehren Dodson
Journal:  Stem Cells Int       Date:  2020-01-30       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.